2m 2m 2m 2m 2m 2m 2m
LARIMAR THERAP (LRMR)
NASDAQ
$3.68$0.00 (0.00%)
Price as of Jun 23, 2026 7:41 PM EDT- $380.2MMarket Cap
- 23.08%1-Year Change
- BiotechnologyIndustry
LARIMAR THERAP (LRMR)
$3.68$0.00 (0.00%)
LRMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.68 | ||
Change | +$0.02 (+0.55%) | ||
Open | $3.63 | ||
High | $3.86 | ||
Low | $3.61 | ||
Previous Close | $3.66 | ||
Volume | 1,977,820 | ||
30-Day Average Volume | 1,934,099 | ||
1-Week Change | 8.24% | ||
1-Month Change | 6.67% | ||
1-Year Change | 23.08% | ||
3-Year Change | 11.18% | ||
5-Year Change | -59.07% | ||
Fundamentals | |||
Shares Outstanding | 103.9M | ||
Total Assets | $208.5M | ||
Market Cap | $380.2M | ||
Enterprise Value | $202.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$29.6M | ||
Free Cash Flow | -$44.7M | ||
EBIT | -$29.6M | ||
EBITDA | -$29.5M | ||
Net Working Capital | $157.2M | ||
EPS | -$0.31 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -12 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue